1. Home
  2. Stocks
  3. Neclife Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Nectar Lifesciences Share Price Nectar Lifesciences

    Small Cap
    ₹34.1
    -0.5 (-1.45%)
    25 April, 2024 15:41 BSE: 532649 NSE: NECLIFEISIN: INE023H01027

    Start SIP in Nectar Lifesciences

    Start SIP

    Nectar Lifesciences Performance

    Day Range

    • Low 34
    • High 35
    ₹ 34

    52 Week Range

    • Low 17
    • High 46
    ₹ 34
    • Open Price34
    • Previous Close35
    • Volume182158

    Nectar Lifesciences Share Price

    • Over 1 Month +8.43%
    • Over 3 Month -4.08%
    • Over 6 Month +51.56%
    • Over 1 Year +98.83%

    Nectar Lifesciences Key Statistics

    P/E Ratio 94.7
    PEG Ratio 0.6
    Market Cap Cr 765
    Price to Book Ratio 0.7
    EPS -2.8
    Dividend 0
    Relative Strength Index 52.33
    Money Flow Index 45.38
    MACD Signal -0.19
    Average True Range 1.95
    Nectar Lifesciences Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 452398394389
    Operating Expenses Qtr Cr 410371359369
    Operating Profit Qtr Cr 42273620
    Depreciation Qtr Cr 15151515
    Interest Qtr Cr 25211820
    Tax Qtr Cr 111-2
    Net Profit Qtr Cr 2125
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,567
    Operating Expenses Annual Cr 1,469
    Operating Profit Annual in Cr 55
    Depreciation Cr 59
    Interest Annual Cr 79
    Tax Annual Cr -18
    Net Profit Annual Cr -22
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 133
    Cash from Investing Activity Annual Cr 52
    Cash from Financing Annual Activity Cr -186
    Net Cash Flow Annual Cr 0
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,065
    Fixed Assets Annual Cr 740
    Total Non Current Assets Annual Cr 772
    Total Current Assets Annual Cr 1,417
    Total Assets Annual Cr 2,189
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 47
    ROE Annual % -2
    ROCE Annual % 3
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 6
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 452398394389
    Operating Expenses Qtr Cr 410371359371
    Operating Profit Qtr Cr 42273618
    Depreciation Qtr Cr 15151515
    Interest Qtr Cr 25211820
    Tax Qtr Cr 111-2
    Net Profit Qtr Cr 2124
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,567
    Operating Expenses Annual Cr 1,471
    Operating Profit Annual in Cr 53
    Depreciation Cr 59
    Interest Annual Cr 79
    Tax Annual Cr -18
    Net Profit Annual Cr -24
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 134
    Cash from Investing Activity Annual Cr 52
    Cash from Financing Annual Activity Cr -186
    Net Cash Flow Annual Cr 0
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,065
    Fixed Assets Annual Cr 740
    Total Non Current Assets Annual Cr 772
    Total Current Assets Annual Cr 1,417
    Total Assets Annual Cr 2,189
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 47
    ROE Annual % -2
    ROCE Annual % 3
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 6
    Sign Up to Know More
    Invest in Nectar Lifesciences

    Nectar Lifesciences Technicals

    EMA & SMA

    Current Price
    ₹34.1
    -0.5 (-1.45%)
    pointer
    • Bullish Moving Average
    • ___
    • 12
    • Bearish Moving Average
    • ___
    • 4
    • 20 Day
    • ₹33.98
    • 50 Day
    • ₹34.23
    • 100 Day
    • ₹33.11
    • 200 Day
    • ₹30.24
    • 20 Day
    • ₹33.74
    • 50 Day
    • ₹35.31
    • 100 Day
    • ₹34.15
    • 200 Day
    • ₹29.43

    Nectar Lifesciences Resistance and Support

    PIVOT
    ₹34.75
    Resistance
    First Resistance 35.75
    Second Resistance 36.90
    Third Resistance 37.90
    RSI 52.33
    MFI 45.38
    MACD Single Line -0.19
    MACD -0.07
    Support
    First Resistance 33.60
    Second Resistance 32.60
    Third Resistance 31.45

    Nectar Lifesciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 446,240 25,413,368 56.95
    Week 287,660 18,044,924 62.73
    1 Month 603,348 32,375,671 53.66
    6 Month 1,802,010 74,170,738 41.16

    Nectar Lifesciences Result Highlights

    Nectar Lifesciences Synopsis

    NSE-Medical-Generic Drugs

    Nectar Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1523.67 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2023. Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664.
    Market Cap 776
    Sales 1,633
    Shares in Float 12.56
    No of funds 13
    Yield 0.22
    Book Value 0.73
    U/D Vol ratio 2.6
    LTDebt / Equity 21
    Alpha 0.17
    Beta 1.27

    Nectar Lifesciences

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 55.8%55.8%55.8%55.8%
    Mutual Funds
    Foreign Portfolio Investors 2.39%1.53%1.43%1.41%
    Individual Investors 23.32%24.34%24.46%24.61%
    Others 18.49%18.33%18.31%18.18%

    Nectar Lifesciences Management

    Name Designation
    Mr. Sanjiv Goyal Chairman & Managing Director
    Dr. Indu Pal Kaur Independent Director
    Mr. Ajay Swaroop Independent Director
    Dr. Rupinder Tewari Independent Director
    Dr. Kuldip Kumar Bhasin Independent Director
    Mr. Puneet Sud Whole Time Director
    Ms. Meena Verma Nominee Director

    Nectar Lifesciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Nectar Lifesciences Corporate Action

    Date Purpose Remarks
    2024-02-14 Quarterly Results
    2023-11-10 Quarterly Results
    2023-08-14 Quarterly Results
    2023-05-26 Audited Results & A.G.M.
    2023-02-14 Quarterly Results

    Nectar Lifesciences MF Shareholding

    Name Amount(cr)

    Nectar Lifesciences FAQs

    What is Share Price of Nectar Lifesciences ?

    Nectar Lifesciences share price is ₹34 As on 25 April, 2024 | 15:27

    What is the Market Cap of Nectar Lifesciences ?

    The Market Cap of Nectar Lifesciences is ₹764.7 Cr As on 25 April, 2024 | 15:27

    What is the P/E ratio of Nectar Lifesciences ?

    The P/E ratio of Nectar Lifesciences is 94.7 As on 25 April, 2024 | 15:27

    What is the PB ratio of Nectar Lifesciences ?

    The PB ratio of Nectar Lifesciences is 0.7 As on 25 April, 2024 | 15:27

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.